• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail

FDA Science Board Advisory Committee Subcommittee: Notice Of Public Meeting April 10, 2007, Regarding CVM’s National Antimicrobial Resistance Monitoring System (NARMS)

March 21, 2007

The Science Board to the FDA (Science Board) National Antimicrobial Resistance Monitoring System (NARMS) Program subcommittee will convene a meeting on April 10, 2007, beginning at 9:00 a.m. at the Hilton Washington DC/Rockville Executive Meeting Center (formerly the DoubleTree Hotel), 1750 Rockville Pike, Rockville, MD 20852. The purpose of the subcommittee will be evaluation of the NARMS program and addressing four questions relevant to the continued success of the program including:

  1. Are there inherent biases in the sampling strategies employed in NARMS? If so, how can they be improved to ensure that the data and interpretation are scientifically sound given current resources?
  2. Are there epidemiological and/or microbiological research studies that would better serve the goals of NARMS and the regulatory work of FDA?
  3. Are current plans for data harmonization and reporting appropriate? If not, what are the top priorities for advancing harmonized reporting?
  4. Are the current NARMS international activities adequate to address the worldwide spread of antimicrobial-resistant foodborne bacteria?

The subcommittee will discuss and hear comments on the NARMS Program, including oral presentations from the public on scope, strengths, weaknesses, and areas for improvement. The subcommittee will provide advice to the Science Board, including information obtained from this public meeting.

Requests to make an oral presentation at the meeting must be submitted by March 28, 2007, to Carlos Pena, Office of Science and Health Coordination, Office of the Commissioner (HF–33), Food and Drug Administration, 5600 Fishers Lane, (for express delivery, rm. 14B–08) Rockville, MD 20857, 301–827–3340, e-mail: Carlos.Pena@fda.hhs.gov. Please include a brief statement of the general nature of the evidence or arguments to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make the presentation.

Registration requests to attend the meeting should be submitted no later than one day in advance of the meeting, or April 9, 2007.

Interested persons may present data, information, or views, orally or in writing, on the issues pending before this subcommittee. Oral presentations from the public will be scheduled at 11:00 a.m. on April 10, 2007. The FDA will try to accommodate all persons who wish to make a presentation. The time allotted for presentations may depend on the number of persons who wish to speak. If the number of registered speakers is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open pubic hearing session. Registered speakers will be contacted prior to the meeting.

If you need special accommodations due to a disability, please notify the hotel (301-468-1100) at least 7 days in advance.

Transcripts of the meeting may be requested in writing from the Freedom of Information Office (HFI-35), Food and Drug Administration, 5600 Fishers Lane, rm. 6-30, Rockville, MD 20857, at a cost of 10 cents per page.


Additional Information


Contact FDA

240-276-9115 FAX
Issued by: FDA, Center for Veterinary Medicine

Communications Staff, HFV-12

7519 Standish Place

Rockville, MD 20855